Literature DB >> 17581906

Eye size in retinoblastoma: MR imaging measurements in normal and affected eyes.

Pim de Graaf1, Dirk L Knol, Annette C Moll, Saskia M Imhof, Antoinette Y N Schouten-van Meeteren, Jonas A Castelijns.   

Abstract

PURPOSE: To evaluate eye size retrospectively by using magnetic resonance (MR) imaging to measure axial length (AL), equatorial diameter (ED), and eye volume (EV) in patients with retinoblastoma and to evaluate the possible effect of retinoblastoma on eye size.
MATERIALS AND METHODS: Local ethics committee approval was obtained with waiver of informed consent. MR images of 100 patients with retinoblastoma (50 girls, 50 boys; mean age, 19 months; age range, 9 days to 68 months) were scored by one observer (AL, ED, EV, and tumor volume measurements), with a second observer reviewing all measurements. Normal eyes of patients with unilateral retinoblastoma served as controls. Interobserver measurement agreement was evaluated in a random subset of 50 eyes with use of intraclass correlation coefficients. Linear mixed model analysis was used with adjustments for age, laterality, and sex.
RESULTS: Interobserver agreement was good (intraclass correlation coefficients >or= 0.89). Eyes with retinoblastoma had significantly shorter ALs (95% confidence interval [CI]: -0.57 mm, -0.16 mm; P=.001) and EDs (95% CI: -1.01 mm, -0.66 mm; P<.001) and significantly smaller EVs (95% CI: -336 mm(3), -151 mm(3); P<.001) than normal eyes. Within patients, a significant negative relationship was found between tumor volume and EV (P<.001).
CONCLUSION: MR imaging measurements of AL, ED, and EV were significantly smaller in eyes with retinoblastoma than in normal eyes. In addition, in patients with retinoblastoma, the larger the tumor volume, the smaller the eye. (c) RSNA, 2007.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581906     DOI: 10.1148/radiol.2441060456

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

1.  Single-shot turbo spin-echo diffusion-weighted imaging for retinoblastoma: initial experience.

Authors:  P de Graaf; P J W Pouwels; F Rodjan; A C Moll; S M Imhof; D L Knol; E Sanchez; P van der Valk; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-27       Impact factor: 3.825

Review 2.  MRI of retinoblastoma.

Authors:  A A K A Razek; S Elkhamary
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

Review 3.  Clinical application of MRI in ophthalmology.

Authors:  Kelly A Townsend; Gadi Wollstein; Joel S Schuman
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

Review 4.  Biomarkers in retinoblastoma.

Authors:  Jie Sun; Hui-Yu Xi; Qing Shao; Qing-Huai Liu
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

5.  Ocular volumetry using fast high-resolution MRI during visual fixation.

Authors:  K Tanitame; T Sone; T Miyoshi; N Tanitame; K Otani; Y Akiyama; M Takasu; S Date; Y Kiuchi; K Awai
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-04       Impact factor: 3.825

6.  The value of MRI in evaluating the efficacy and complications with the treatment of intra-arterial chemotherapy for retinoblastoma.

Authors:  Shuxian Chen; Xunda Ji; Ming Liu; Zhengrong Xia; Hui Zheng; Qiufeng Yin; He Wang; Yuhua Li
Journal:  Oncotarget       Date:  2017-06-13

7.  Prevalence of refractive errors in children with retinoblastoma.

Authors:  Victor M Villegas; Shuo-Chieh Wu; Timothy G Murray; Kara M Cavuoto; Hilda Capo; Craig A McKeown
Journal:  Clin Ophthalmol       Date:  2019-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.